Bristol-Myers Squibb Co.

Pharmaceuticals
United States
Executive 1Mr. Lamberto Andreotti, ; Chief Executive Officer; Subsidiary Officer | ; Chief Executive Officer; Subsidiary Officer
Executive 2Dr. Giovanni Caforio, M.D., Incoming Chief Executive OfficerChief Operating Of | PresidentChief Operating Officer; Chief Commercial
Earnings Per Share Growth (%)-22.08%
Cost of Goods Sold (US$ Millions)$3,932
Current Liabilities (US$ Millions)$8,461
Total Assets (US$ Millions)$14,608
Long Term Debt (Millions)$7,242
Return on Equity13.22%
Revenue (US$ Millions)$15,879
Total Company Assets$33,749
Revenue Growth (%)-3.09%
Net Income (US$ Millions)$2,004
Earnings Per Share (US$)$1.20
Total Equity (US$ Millions)$14,852
Profit Margin (%)12.62%
Debt To Equity Ratio (%)0.49%
Inventories (Millions)$1,560